Efficacy of targeted education in reducing topical steroid phobia: A randomized clinical trial - 09/11/20
Abstract |
Background |
Fear of adverse effects of corticosteroids is common in dermatology and results in medication nonadherence.
Objective |
To study the efficacy of targeted education in reducing topical steroid phobia.
Methods |
In this double-blinded, randomized controlled trial, participants in the intervention arm were presented with an educational video and patient information leaflet targeting common misconceptions of topical corticosteroids. Steroid phobia was assessed with the topical corticosteroid phobia (TOPICOP) scale, medication adherence with the Elaboration d'un outil d'evaluation de l'observance des traitements medicamenteux (ECOB) score, and quality of life with the Dermatology Life Quality Index (DLQI).
Results |
The study randomized 275 patients. The mean TOPICOP score in the intervention arm decreased (improved) from 41.9 (SD, 17.4) to 37.1 (SD, 20.0) and to 33.8 (SD, 19.0) at 1 month and 3 months, respectively, with the reduction arising from the knowledge domain but not the fears and behaviors domain. This remained statistically significant after adjusting for demographic confounding with an expected reduction of 4.22 points (P = .031). After accounting for demographic factors, there was no statistical difference in medication adherence and quality of life. Limitations include the exclusion of non–English-speaking patients.
Conclusion |
Targeted education at a single time point improved the TOPICOP score primarily in the knowledge domain but not in the fear domain.
Le texte complet de cet article est disponible en PDF.Key words : atopic dermatitis, health services research, patient education, randomized controlled trial, steroid phobia, topical corticosteroids, topical steroid concern
Abbreviations used : CI, DLQI, ECOB, TCS, TOPICOP
Plan
Ellie Choi and Ken Wei Tan are cofirst authors, and Chris Tan and Nisha Suyien Chandran are colast authors. |
|
Funding sources: This study was funded by a health services research grant from the National University Health System and National University Singapore. |
|
Conflicts of interest: None disclosed. |
|
IRB approval status: The National Healthcare Group Domain Specific Review Board approved the study (DSRB Ref. No. 2018/00481). |
|
Reprints not available from the authors. |
Vol 83 - N° 6
P. 1681-1687 - décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?